Physician profile
Stephen D Confer
NPI 1841345709
$6,387.54
in general payments reported to CMS, 2019-2025
48 companies · $1,025 in 2025
The $1,025 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $680 · 2020: $666 · 2021: $1,271 · 2022: $1,269 · 2023: $1,115 · 2024: $362 · 2025: $1,025.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,401 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,401.27 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $1,074.04 | 2019-2023 | Xtandi |
| Coloplast Corp | $621.81 | 2020-2023 | Porges Coloplast, Speedicath |
| Janssen Biotech, INC. | $352.70 | 2019-2025 | Erleada |
| Procept Biorobotics Corporation | $321.22 | 2020-2025 | Aquabeam Robotic System |
| Novartis Pharmaceuticals Corporation | $282.05 | 2022-2025 | |
| Verity Pharmaceuticals INC. | $275.42 | 2022-2024 | Trelstar |
| Urogen Pharma, INC. | $226.04 | 2021-2025 | |
| Dendreon Pharmaceuticals LLC | $224.94 | 2019-2025 | Provenge |
| Pfizer INC. | $220.65 | 2019-2025 | |
| Smith+Nephew, INC. | $219.72 | 2022-2025 | N/A |
| Teleflex LLC | $208.96 | 2022-2023 | Urolift |
| Calyxo, INC. | $199.64 | 2025 | Cvac Aspiration System |
| Boston Scientific Corporation | $170.47 | 2019-2023 | Lithovue |
| Endo Pharmaceuticals INC. | $150.46 | 2020-2024 | Xiaflex |
| Blue Earth Diagnostics | $136.21 | 2019-2024 |
Show all 46 companies
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$340,127.28 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Confer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.